Apogee Therapeutics Stock (NASDAQ: APGE) stock price, news, charts, stock research, profile.
You can purchase shares of Apogee Therapeutics (NASDAQ:APGE) through any online brokerage.
Other companies in Apogee Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX) and TG Therapeutics (NASDAQ:TGTX).
Apogee Therapeutics has a consensus price target of $70.67.
The stock price for Apogee Therapeutics (NASDAQ: APGE) is $57.31 last updated October 1, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Apogee Therapeutics.
Apogee Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Apogee Therapeutics.
Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.